700
Views
10
CrossRef citations to date
0
Altmetric
Atopic Dermatitis & Urticaria

Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study

, , &
Pages 548-550 | Received 23 Jan 2015, Accepted 23 Feb 2015, Published online: 17 Apr 2015

References

  • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43
  • Chow S. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Association Allergy Asthma Clin Immnunol. 2012;2:149–60
  • Fedorowicz Z, van Zuuren E, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012;3:CD008596
  • MŁynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63:777–80
  • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417–26
  • Weldon R. Quality of life in patients with urticaria. Allergy Asthma Proc. 2006;2:96–9
  • Valero A, Herdman M, Bartra J, et al. Adaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol. 2008;18:426–32
  • Aguilar-Hinojosa N, Segura-Méndez N, Lugo-Reyes S. Correlación de la gravedad de urticaria crónica y calidad de vida. Rev Alergia México. 2012;59:180–6
  • Maurer M, Magerl M, Metz M, Zuberbier T. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J Dtsch Dermatol Ges. 2013. [Epub ahead of print]. doi: 10.1111/ddg.12194
  • Cook J, Shuster S. Lack of effect of H2 blockade in chronic urticaria. Br J Dermatol. 1979;101:21–2
  • Monroe E, Cohen S, Kalbfleisch J, Schulz C. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.